New York, New York (PRWEB) June 10, 2015

The Conference Forum is delighted to announce its top-tier industry keynote speakers for the 5th annual Partnership Opportunities in Drug Delivery (PODD) event to be held Oct. 5 – 6 at the InterContinental Boston.

The two-day event will be kicked-off by serial entrepreneur and renowned chemical engineer, Dr. Robert Langer, the David H. Koch Institute Professor at MIT. The Langer lab is the largest biomedical engineering laboratory in the world, with more than 100 researchers and annual grants in excess of $ 10 million. Dr. Langer’s PODD keynote address will focus on nanotechnology, a field that has the potential to revolutionize the way we detect and treat human diseases. Dr. Langer has been involved with the founding of multiple nanotechnology-based companies including BIND Therapeutics, Blend Therapeutics, Kala Pharmaceuticals, and Selecta Biosciences.

We are equally excited to welcome Keynote, Dr. Bahija Jallal, Head of MedImmune and Executive Vice President, AstraZeneca and her colleague, Dr. Anand Subramony, Head of Drug Delivery, MedImmune, for a joint industry talk. Dr. Jallal will discuss the company’s pipeline and strategy, while Dr. Subramony will highlight some of the 15+ drug delivery collaborations the company has engaged in over the past year.

Mr. Stéphane Bancel, CEO, Moderna Therapeutics will kick-off Day Two of the PODD event, as our featured CEO keynote. Moderna Therapeutics is a leading innovator of messenger RNA therapeutics and has been recognized by CNBC as the country’s most ambitious and innovative companies changing the economy and overall business landscape.

PODD Chair Dr. Barbara Lueckel of Roche said: “The PODD event combines outstanding keynotes and speakers with the latest innovations in the drug delivery industry, including delivery technologies for oncology, patch pump delivery systems, delivery of RNA therapeutics, and drug delivery to the back-of-the-eye”. In addition, Sanofi will lead a device case study along with two partner companies, and delegates will have the opportunity to hear from more than 40 companies presenting innovative drug delivery technologies.

The PODD event features extensive networking opportunities throughout the program as well as an exhibit hall with more than 35 vendors. Companies participating in this year’s event include 3M Drug Delivery Systems, Alcyone Lifesciences Inc., Abbvie, Allergan, Inc., Alnylam Pharmaceuticals, Inc., Amgen, Arrowhead Research Corporation, AstraZeneca Research & Development, Oncology iMed, AstraZeneca, Biocorp, Biogen Idec, Brigham and Women’s Hospital, Buehler Motor, Inc., Cambridge Consultants, Capricor Therapeutics, Inc., Carnegie Mellon University, Credence Medsystems, Cyta Therapeutics, DCA Design International, Dicerna Pharmaceuticals, Enable Injections, LLC, F. Hoffmann-La Roche AG, Genentech, GSK, Innocore Pharma, Insulet Corporation, Janssen, Johns Hopkins University School of Medicine, Lucideon, MedImmune, MedPharm, MERCK KGaA / EMD Serono, Inc., MIT, Moderna Therapeutics, Novartis, Novo Nordisk, Novozymes, Onyx Pharmaceutical, Pfizer, Pfizer BioTherapeutics, PharmaCircle, LLC, Phillips-Medisize Corporation, Polysciences, Portal Instruments, Renishaw, Salvona Technologies, Sanofi, Sanofi-Genzyme BioVentures, Sensile, Silence Therapeutics, Starpharma, Stress Engineering Services, Team Consulting Ltd, Tergus Pharma, Teva Pharmaceuticals, Unilife, Vectura Limited, and more.

For more information, visit http://theconferenceforum.org/conferences/partners-in-drug-delivery/overview/.

About The Conference Forum

The Conference Forum has a very specific focus – developing specialized events both public and private as well as research groups and advisory boards for professionals in the life science industry. Its mission is to create the best content in an ideal forum for the exchange of ideas among peers and networking for Pharmaceutical and Biotech professionals.






Find More Medicine Press Releases

Tags